Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Randomized Controlled Trial

Case Reports

Multicenter Study

Clinical Trial, Phase II

Research Support, U.S. Gov't, P.H.S.

Clinical Trial

Meta-Analysis

Research Support, N.I.H., Extramural

Clinical Trial, Phase III

Clinical Trial, Phase I

Comparative Study

Systematic Review

Consensus Development Conference

Practice Guideline

Observational Study

Network Meta-Analysis

Clinical Trial Protocol

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2018

2017

2016

2014

2013

2012

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Cytochrome P-450 CYP11B2""[mesh_terms]

71 Results

Searching titles within these results

Genetic alterations in patients with primary aldosteronism.

Y Takeda

Hypertension research : official journal of the Japanese Society of Hypertension 2002;24(5):469-74

Free Full Text

Abstract

Aldosterone synthase deficiency due to homozygous CYP11B2 pathogenic variant with coexisting celiac disease: A case study and literature review.

Zuzanna Gawlik, Konrad Kaleta, Martyna Wróblewska, Maria Szwarkowska, Ewelina Preizner-Rzucidło, Krystian Jażdżewski, Sebastian Wardak, Jerzy B Starzyk, Dominika M Januś

Pediatric endocrinology, diabetes, and metabolism 2025;31(3):133-140

Full Text

Abstract

Familial hyperaldosteronism.

D J Torpy, C A Stratakis, G P Chrousos

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologica 2000;33(10):1149-55

Free Full Text

Abstract

Classic and current concepts in adrenal steroidogenesis: a reappraisal.

Claudio E Kater, Rafael B Giorgi, Flavia A Costa-Barbosa

Archives of endocrinology and metabolism 2022;66(1):77-87

Free Full Text

Abstract

Role of aldosterone availability in preeclampsia.

Markus Mohaupt, Geneviève Escher

Molecular aspects of medicine 2007;28(2):245-54

Full Text

Abstract

Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertension.

Jacob George, Cyril Kocherry, Chai Eddison Chung Hung

Journal of hypertension 2025;43(8):1286-1295

Full Text

Abstract

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.

Deepak L Bhatt, Morris J Brown, Ajay Srivastava, Mason W Freeman, Yuan-Di Halvorsen, William Marshall, Mackenzie Pater, Jon Isaacsohn, Catherine Pearce, Brian Murphy, Nicholas Alp

The New England journal of medicine 2023;388(5):395-405

Full Text

Abstract

Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism.

Yuichi Yoshida, Hirotaka Shibata

Hypertension research : official journal of the Japanese Society of Hypertension 2025;48(2):854-861

Full Text

Abstract

Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review.

Hui Miao, Zhongxun Yu, Lin Lu, Huijuan Zhu, Richard J Auchus, Jiayan Liu, Jun Jiang, Hui Pan, Fengying Gong, Shi Chen, Zhaolin Lu

Steroids 2020;150():108448

Free Full Text

Abstract

Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence.

Lucas Maciel de Almeida Corrêa, Luiggi Kevin Virgino Brandão, Clara Belo Gamon Santiago, Alexandre de Assis Barbosa, Gabriel Rian Mazur, Gabriel Costa de de Santana, Yan Roberth Delmiro Silva, Letícia Esteves Dante, Ivan Felipe Dutra Júnior

Clinical transplantation 2026;40(5):e70555

Full Text

Abstract

Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance.

Yasuhiro Nakamura, Yuto Yamazaki, Yuta Tezuka, Fumitoshi Satoh, Hironobu Sasano

The Tohoku journal of experimental medicine 2017;240(3):183-190

Free Full Text

Abstract

CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.

Hans-Rudolf Brunner, Stuart Hossack, Ashley Brooks, Ronald Edward Steele, Christoph Schumacher, Bruno Vogt, Michael Groessl, Paolo Mulatero

British journal of clinical pharmacology 2023;89(8):2483-2496

Free Full Text

Abstract

Altered corticosteroid biosynthesis in essential hypertension: A digenic phenomenon.

Eleanor Davies, Scott M Mackenzie, E Marie Freel, Samantha Alvarez-Madrazo, Robert Fraser, John M C Connell

Molecular and cellular endocrinology 2009;300(1-2):185-91

Full Text

Abstract

Glucocorticoid-remediable aldosteronism.

Robert G Dluhy, Graham T McMahon

Cardiology in review 2004;12(1):44-8

Full Text

Abstract

New genetic insights in familial hyperaldosteronism.

Richard V Jackson, Anthony Lafferty, David J Torpy, Constantine Stratakis

Annals of the New York Academy of Sciences 2002;970():77-88

Full Text

Abstract

Results: 1 – 15 / 71

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Cytochrome P-450 CYP11B2""[mesh_terms]

Genetic alterations in patients with primary aldosteronism.

Aldosterone synthase deficiency due to homozygous CYP11B2 pathogenic variant with coexisting celiac disease: A case study and literature review.

Familial hyperaldosteronism.

Classic and current concepts in adrenal steroidogenesis: a reappraisal.

Role of aldosterone availability in preeclampsia.

Breaking down resistance: novel aldosterone synthase inhibitors in the management of resistant hypertension.

Phase 2 Trial of Baxdrostat for Treatment-Resistant Hypertension.

Evolution of mineralocorticoid receptor antagonists, aldosterone synthase inhibitors, and alternative treatments for managing primary aldosteronism.

Analysis of novel heterozygous mutations in the CYP11B2 gene causing congenital aldosterone synthase deficiency and literature review.

Aldosterone Synthase Inhibition in Kidney Transplantation: Class Rationale, Translational Promise, and the Limits of Current Evidence.

Expression of CYP11B2 in Aldosterone-Producing Adrenocortical Adenoma: Regulatory Mechanisms and Clinical Significance.

CYP11B2 inhibitor dexfadrostat phosphate suppresses the aldosterone-to-renin ratio, an indicator of sodium retention, in healthy volunteers.

Altered corticosteroid biosynthesis in essential hypertension: A digenic phenomenon.

Glucocorticoid-remediable aldosteronism.

New genetic insights in familial hyperaldosteronism.

Results for
""Cytochrome P-450 CYP11B2""[mesh_terms]